Filter results
You can narrow down the results using the filters
Topics
Our work
Diseases
11455 results
-
ATAGI advice: Gardasil®9 in the school-based NIP
Australian Technical Advisory Group on Immunisation (ATAGI) advice on the introduction of Gardasil®9 in a 2-dose schedule under the school-based National Immunisation Program (NIP). -
Deed for the provision of Overseas Student Health Cover 1 July 2016
This legal document sets out the conditions that registered Australian health funds must comply with to provide Overseas Student Health Cover (OSHC) policies. -
Medical Research Future Fund (MRFF) Funding Principles
The 16 MRFF funding principles will guide the allocation of MRFF research funding. All disbursements will occur in accordance with the MRFF Act 2015. -
Application Form to Transfer Home Care Services to Another Approved Provider
This form is for home care providers. Use this form if you want to transfer one of your Home Care Package services to another approved provider. -
Aged Care Diversity Framework
This framework was launched in December 2017. It sets out the actions we can take to make sure aged care services meet the needs of people from diverse backgrounds. It sees a role for the Australian Government, peak organisations, representative groups, service providers, consumers and carers. -
National Cervical Screening Program – data requirements for pathologists
Find out what information pathologists need to notify to the National Cancer Screening Register about cervical screening tests. -
The prevalence of different types of speech, language and communication disorders and speech pathology services in Australia
Australian Government response to the Senate Community Affairs References Committee report: The prevalence of different types of speech, language and communication disorders and speech pathology services in Australia -
Aged Care Changes Campaign – Quantitative Benchmarking and Evaluation
The 2017 aged care advertising campaign aimed to raise awareness of My Aged Care and encourage older people, their families and carers to plan for aged care. This report examines the effectiveness of the 2017 aged card advertising campaign. -
Thinking Ahead – Report on the Inquiry into Dementia: Early Diagnosis and Intervention
Australian Government response to the House of Representatives Standing Committee on Health and Ageing report Thinking Ahead – Report on the Inquiry into Dementia: early diagnosis and intervention -
Senate Select Committee on Health first interim report
Australian Government response to the Senate Select Committee on Health First Interim Report -
Care and Management of Australians Living with Dementia
Australian Government response to the Senate Community Affairs References Committee report: Care and management of younger and older Australians living with dementia and behavioural and psychiatric symptoms of dementia (BPSD) -
Action plan – Enhanced response to addressing sexually transmissible infections (and bloodborne viruses) in Indigenous populations
The plan supports the national response to the disproportionately high rates of sexually transmitted infections and bloodborne viruses in Aboriginal and Torres Strait Islander peoples. -
Emergency Medicine – Australia’s Future Health Workforce report
This report presents long-term, national workforce projections for emergency medicine doctors to 2030. It is part of our series on Australia’s Future Health Workforce. -
Q fever – Laboratory case definition
The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for Q fever. -
National Health Genomics Policy Framework 2018–2021
Genomics has the potential to improve the health of all Australians by helping doctors prevent, diagnose, treat and monitor diseases. This framework provides a nationally consistent approach to policy, regulatory and investment decisions about integrating genomics into our health system. -
ANACAD summary of activities 2016–17
An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2016 to 30 June 2017. -
National Bowel Cancer Screening Program policies
The National Bowel Cancer Screening Program is supported by a number of frameworks and strategies. They guide how the program is delivered and make sure that high standards are maintained and best practice followed. -
24-hour movement guidelines – birth to 5 years – brochure
Being active is important for babies and young children to be healthy, and sets good habits for life. This brochure outlines how much activity small children should do each day, how sitting time and screen time should be avoided or limited and how much sleep they should get. -
24-hour movement guidelines – birth to 5 years – fact sheet
Being active is important for babies and young children to be healthy, and sets good habits for life. Read about how much activity small children should do each day, how sitting time and screen time should be avoided or limited, and how much sleep they should get. -
Short-Term Restorative Care Programme Manual
This manual guides service delivery under the Short-Term Restorative Care Programme. -
Supporting Living Organ Donors Program application form
Eligible donors complete this form and submit to livingorgandonation@health.gov.au. -
National Bowel Cancer Screening Program – Policy Framework
This framework supports the National Bowel Cancer Screening Program. It outlines best practices in implementing the Program, the screening process itself and how the Program will be managed and reviewed. -
Australian National Breastfeeding Strategy – Report on stakeholder consultations, October 2017
This report summarises the finding from consultations held in April and May 2017 to inform the development of an enduring National Breastfeeding Strategy. -
Availability of new, innovative and specialist cancer drugs in Australia
Australian Government response to the Senate Community Affairs References Committee Report: Availability of new, innovative and specialist cancer drugs in Australia -
MDAF communique – 27 November 2017
A summary of the major items discussed at the third MDAF meeting.